Search research articles
Contact Us
Filters
Showing results (461-470 of 492) with videos related to
Page
of 50
Sort By:
NPJ Precision Oncology
|
March 3, 2021
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication
Yueshuo Li, Feng Shi, Jianmin Hu, et al.
The Journal of Pathology
|
August 24, 2017
Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma
Li-Jie Ma, Xiao-Ying Wang, Meng Duan, et al.
Oncotarget
|
December 18, 2015
Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity
Jie-Yi Shi, Qingfeng Xing, Meng Duan, et al.
Oncogene
|
August 17, 2019
GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH
Rui Yang, Na Liu, Ling Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2017
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma
Yun-Fan Sun, Wei Guo, Yang Xu, et al.
Oncotarget
|
October 31, 2015
Grifolin directly targets ERK1/2 to epigenetically suppress cancer cell metastasis
Xiangjian Luo, Lifang Yang, Lanbo Xiao, et al.
The Journal of Headache and Pain
|
October 27, 2022
Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China
Shuhua Zhang, Ya Cao, Fanhong Yan, et al.
Journal of Hepatology
|
March 22, 2017
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang, Xin Zhao, Xin-Rong Yang, et al.
Molecular Oncology
|
February 22, 2018
IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer
Jiang-Jiang Li, Ruilei Li, Wenxiang Wang, et al.
Annals of Surgical Oncology
|
April 8, 2018
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma
Xiao-Lu Ma, Mi Jiang, Ying Zhao, et al.
Page
of 50
Search research articles
Search
Showing results (461-470 of 492) with videos related to
Sort By:
Page
of 50
NPJ Precision Oncology
|
March 3, 2021
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication
Yueshuo Li, Feng Shi, Jianmin Hu, et al.
The Journal of Pathology
|
August 24, 2017
Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma
Li-Jie Ma, Xiao-Ying Wang, Meng Duan, et al.
Oncotarget
|
December 18, 2015
Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity
Jie-Yi Shi, Qingfeng Xing, Meng Duan, et al.
Oncogene
|
August 17, 2019
GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH
Rui Yang, Na Liu, Ling Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2017
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma
Yun-Fan Sun, Wei Guo, Yang Xu, et al.
Oncotarget
|
October 31, 2015
Grifolin directly targets ERK1/2 to epigenetically suppress cancer cell metastasis
Xiangjian Luo, Lifang Yang, Lanbo Xiao, et al.
The Journal of Headache and Pain
|
October 27, 2022
Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China
Shuhua Zhang, Ya Cao, Fanhong Yan, et al.
Journal of Hepatology
|
March 22, 2017
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang, Xin Zhao, Xin-Rong Yang, et al.
Molecular Oncology
|
February 22, 2018
IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer
Jiang-Jiang Li, Ruilei Li, Wenxiang Wang, et al.
Annals of Surgical Oncology
|
April 8, 2018
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma
Xiao-Lu Ma, Mi Jiang, Ying Zhao, et al.
Page
of 50